| 1998-2000 | INTAS-Coordination representative, Bologna, Minsk | |
| 1998-1999 | Coorperation Bayer AG | |
| 1998-1999 | Cooperation DuMont | |
| 1996-2005 | Cooperation Hans-Knöll-Institute | |
| 1996-1999 | Henkel KGaA | |
| 1996-1999 | Deutsche Forschungsgemeinschaft | SCHM1012-1 |
| 1997-1999 | EVOTEC OAI, Hamburg | |
| 1995-1999 | DAAD/SI Prof. Anders Hallberg, Uppsala Universitet, SE | |
| 1997-2002 | Fonds der Chemischen Industrie | |
| 2002-2007 | Schwerpunktprogramm DFG Alzheimer SPP 1085 | SCHM1012-3 |
| 2003-2004 | Novartis Pharma AG, Basel: NMR Probes | |
| 2004-2007 | EU Framework 6: integrated project: APOPIS | Verum Foundation |
| 2004-2006 | MSD Germany | |
| 2004- | Roche, Basel: CNS | |
| 2005-2007 | Schering AG, Berlin: CNS | |
| 2005-2007 | BMBF: TSE – Neurodegenerative Diseases | Prion Protein |
| 2005-2007 | DAAD | |
| 2007- | BMBF Kompetenznetz Degenerative Demenzen KNDD (opens in new tab) | BMBF Information on AD Research (opens in new tab) |
| 2008-2011 | EU Framework 7: Neuro.GSK3 | |
| 2010-2013 | BMBF MINDE – Molecular Diagnosis of Neurodegenerative Diseases in the Eye | |
| 2011- | DFG GrK – Molecular and Cellular Reactions of Ionizing Radiation | |
| 2012 | Breuer-Stiftung – Research Award on Alzheimer Disease |